Each year there are more than 30,000 new cases of pancreatic cancer

Mission Statement

Each year there are more than 30,000 new cases of pancreatic cancer in the United States, and an additional 60,000 cases diagnosed in Europeans.  According to the American Cancer Society (ACS), pancreatic cancer is the 9th or 10th most commonly diagnosed cancer (the rank depends upon gender) and the 3rd leading cause of cancer death in men and 4th among women. Because of the current general inability to diagnose this cancer early, most patients are diagnosed after the cancer has reached ad advanced stage and the survival rate in such cases is among the worst of all cancers (4% five-year survival rate versus 62% for all other cancers combined). Data from the ACS indicates that the median survival period from such a diagnosis of untreated, advanced cancer is 3 1/2 months, which increases to 6-months with effective treatment.  Pancreatic cancer accounts for 2% of the diagnosed cases of cancer in the U.S., yet represents 5% of cancer deaths; overall cancer is the second major cause of death in the U.S., after cardiac pathologies.